Credissential arranges $500,000 private placement
None
On October 15 and 16, 2025, Credissential Inc. announced it is arranging a non-brokered private placement of up to $500,000 in unsecured convertible notes. The key terms of the financing are: * Security: Unsecured convertible notes. * Maturity: 12 months from the closing date. * Conversion: Convertible at the holder's option into common shares at a price of $0.05 per share, or a lower price if permitted by the Canadian Securities Exchange (CSE). * Use of Proceeds: Intended for general corporate and working capital purposes.
In conjunction with this, the company announced the grant of 7,000,000 Restricted Share Units (RSUs) to certain consultants under its Omnibus Equity Incentive Plan. These RSUs are subject to a standard four-month-and-one-day hold period.
The news is negative. While raising capital is necessary for a company in this position, the context reveals a company in severe financial distress.
- Extreme Financial Duress: The company's stock price has collapsed from a 52-week high of $0.25 to an effective price of $0.00. Raising a mere $500,000 for "working capital" confirms the company is operating on fumes and requires this capital simply to continue existing, rather than for growth or expansion.
- Highly Dilutive Terms: The conversion price of the notes is set at $0.05, which is significantly higher than the last traded price. However, the clause allowing for conversion at a "lower amount as allowed" is a major red flag, suggesting a potential repricing that could lead to massive dilution for existing shareholders. If the full $500,000 is raised and converted at $0.05, it would create 10 million new shares. If repriced lower, the share issuance would be even greater.
- Shareholder Dilution via RSUs: The grant of 7,000,000 RSUs to consultants is a substantial giveaway of equity. For a company with a near-zero stock price, this indicates an inability to pay consultants in cash and represents significant future dilution that will weigh on any potential share price recovery.
This financing is a survival mechanism, not a strategic investment. It highlights a critical need for cash and is being done on terms that are detrimental to common shareholders. It is a classic "life-line" financing that signals the company is at high risk of failure.
Information regarding the company's business model, industry, flagship projects, or any operational assets is not provided in the news releases. This is a critical omission and a major red flag for any potential investor. The name "Credissential" may imply operations in the financial or credit sector, but this is pure speculation.